Our data indicate that the cervical tumour cells express markers associated with activation of the immune system (CD95 and MICA/B), as well as markers related to inhibition of the immune system (CD73, CD39, CTLA-4, and CD25). The gene discussed is ENTPD1; the disease is uterine cervix neoplasm.